BioSpace News Archive

Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), today announced that it will host a conference call at 1:00 PM Eastern Time on Thursday, August 11, 2022, to discuss the Company’s corporate progress and other developments, as well as financial results for first quarter 2023 ended June 30, 2022.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Increasing maternal age is one of the main reasons behind growing cases of children born with chromosomal abnormalities such as Down syndrome and Tuner’s syndrome.

Astellas Pharma Inc. announced the following changes to its management structure effective October 1, 2022.

Laser therapy modality forms a valuable tool in the repertoire of veterinary practitioners for surgical and therapeutic purposes.

Safety needles can be characterized as an empty bore needle which is considered to decrease or lessen the likelihood of a skin cut harm to the specialist.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Telehealth, also known as telemedicine or e-health, is the healthcare services delivery through remote settings.

CSL Limited is pleased to announce it has now received all necessary regulatory clearances for the acquisition of Vifor Pharma AG announced on 14 December 2021.

Nyxoah SA announced that the Company has entered into a distribution agreement with Acurable SL, a venture-backed medical device company developing wearable technologies for home use, to provide the AcuPebble SA100 home sleep test to OSA patients in Germany.

Vimian Group has acquired Heiland GmbH, a leading online ordering platform offering veterinary pharmaceuticals and other veterinary products to veterinary clinics across Germany.

Syneos Health, the only fully integrated biopharmaceutical solutions organization, reported financial results for the three and six months ended June 30, 2022.